-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2017 to Q1 2024.
- Heron Therapeutics, Inc. /De/ Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $689K, a 4.04% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Depreciation, Depletion and Amortization for 2023 was $2.9M, a 0.35% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Depreciation, Depletion and Amortization for 2022 was $2.89M, a 4.37% decline from 2021.
- Heron Therapeutics, Inc. /De/ annual Depreciation, Depletion and Amortization for 2021 was $3.02M, a 6.11% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)